43 results
Keyword Advagraf Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Advagraf
tacrolimus, Graft Rejection
Date of authorisation: 23/04/2007, Revision: 21, Authorised, Last updated: 06/05/2020Advagraf Graft Rejection … Advagraf … quot;Advagraf, INN-tacrolimus"; " Advagraf, INN-tacrolimus" European … -
List item
Press release: European Medicines Agency agrees to precautionary recall of Advagraf 0.5 mg capsule batches
CHMP, Last updated: 20/10/2011to precautionary recall of Advagraf 0.5 mg capsule batches … to precautionary recall of Advagraf 0.5 mg capsule batches … to precautionary recall of Advagraf 0.5 mg capsule batches … -
List item
Human medicine European public assessment report (EPAR): Tacforius
tacrolimus monohydrate, Liver Transplantation, Kidney Transplantation
Date of authorisation: 08/12/2017,, Revision: 3, Authorised, Last updated: 29/04/2020
European Union (EU) called Advagraf. How is Tacforius used? Tacforius … with the reference medicine, Advagraf, and do not need to be repeated … and to be bioequivalent to Advagraf. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Envarsus
tacrolimus, Graft Rejection
Date of authorisation: 18/07/2014, Revision: 8, Authorised, Last updated: 07/12/2020medicine for Envarsus is Advagraf. How is Envarsus used? Envarsus … to the reference medicine Advagraf, the applicant provided comparative … provided comparative data on Advagraf. In addition, because of the … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 October 2011
CHMP, Last updated: 21/10/2011Marketing authorisation holder Advagraf tacrolimus Astellas Pharma … -
List item
National expert: Katarina Tepsic Stupica, Agency for medicinal products and medical devices of the Republic of Slovenia (updated)
- Declaration of interests - 80.61 KB | PDF
- Curriculum Vitae - 21.29 KB | PDF
45 mg Prostate Cancer Advagraf & Prograf Immuno supression … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021EPIDYOLEX (CAP); tacrolimus - ADVAGRAF (CAP), ENVARSUS (CAP), MODIGRAF … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 29/01/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 14-17 September 2020
Virtual meeting, from 14/09/2020 to 17/09/2020, Last updated: 14/09/2020 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 16/02/2021 -
List item
European Union regulatory workshop on medication errors
European Medicines Agency, London, UK, from 28/02/2013 to 01/03/2013, Last updated: 13/05/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 March 2014
European Medicines Agency, London, UK, from 03/03/2014 to 06/03/2014, Last updated: 13/08/2013 -
List item
Download medicine data
Last updated: 29/04/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/02/2021 to 25/02/2021, Last updated: 04/11/2019 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 July 2014
European Medicines Agency, London, UK, from 07/07/2014 to 10/07/2014, Last updated: 13/08/2013 -
List item
Healthcare Professionals' Organisations Working Group (HCP WG)
London, UK, 28/10/2011, Last updated: 19/12/2011 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 November-3 December 2015
European Medicines Agency, London, UK, from 30/11/2015 to 03/12/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 October 2013
European Medicines Agency, London, UK, from 07/10/2013 to 10/10/2013, Last updated: 02/07/2012 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018
European Medicines Agency, London, UK, from 11/06/2018 to 14/06/2018, Last updated: 10/08/2018 -
List item
Public data from Article 57 database (updated)
Last updated: 16/02/2021